Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Philippe Ravaud Loïc Guillevin |
| Publication date | April 25, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |